Uwe Siebert

Adjunct Professor of Health Policy and Management

Department of Health Policy and Management

Department of Epidemiology

718 Huntington Avenue
2nd Floor
Boston, Massachusetts 02115


Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, Medical Decision Making and Health Technology Assessment (HTA), is the Chair of the Department of Public Health, Health Services Research and HTA at UMIT – University for Health Sciences, Medical Informatics and Technology in Austria and the Director of the Division for HTA in the ONCOTYROL – Center for Personalized Cancer Medicine in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard Chan School of Public Health and Director of the Program on Cardiovascular Research at the Institute for Technology Assessment and Department of Radiology at the Massachusetts General Hospital, Harvard Medical School, Boston. He is the course director of the Harvard summer course on ‘Decision Analysis in Clinical Research’ and he has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.

After medical school, he worked for several years as a physician in international public health projects in West-Africa, Brazil, and Germany. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and a ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis.

Prof. Siebert is the President of the Society for Medical Decision Making (SMDM), a member of the Latin America Consortium Advisory Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the ‘National HTA Strategy’ Expert Group of the Austrian Federal Ministry of Health, a member of the Oncology Advisory Council of the Federal Ministry of Health in Austria, a member of the Advisory Board of the GÖG – National Austrian Public Health Institute, a member of the Directors Board of the German Competence Network Heart Failure, a member of the Austrian Cochrane Collaboration Branch, and a member of several national and international Directors and Trustees Boards (Society for Medical Decision Making; Austrian Society of Epidemiology, German Network of EbM; German Association for Medical Informatics, Biometry and Epidemiology). He has served as Vice President of SMDM, member of the ISPOR Board of Directors, member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions, member of the Harvard Flagship Initiative in Comparative Effectiveness Research, member of the Extended Board of Directors of the German Association of Health Economics, and member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria.

He is the Clinical Guideline Commissioner for the Association of the Scientific Medical Societies in Germany (AWMF) and the Chairman of the Working Groups ‘Health Economics’ and ‘Medical Decision Making’ of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force, Co-Chair of the ‘Issues in Methodology Section’ of the SMDM Policy Initiative, and a Leadership Member of the ISPOR Personalized/Precision Medicine Special Interest Group.

He has worked with several HTA Agencies (e.g., DAHTA@DIMDI/Germany, IQWiG/Germany, NICE/UK, ANVISA/Brazil, CADTH/Canada, LBI-HTA/Austria, GOEG/Austria) and he advises government agencies, academic institutions and industry regarding the conduction and impact of health technology assessments on policy and reimbursement decisions. He has authored more than 350 publications including HTA reports, textbook chapters, scientific articles, and editorials, and is Editor of the European Journal of Epidemiology, Associate Editor of the International Journal of Public Health as well as editorial board member of several scientific journals.


Prof. Siebert’s research interests include applying evidence-based quantitative and translational methods from public health, epidemiology, comparative effectiveness research, health services and outcomes research, economic evaluation and decision sciences in the framework of HTA as well as in the clinical context of routine health care and patient guidance. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, neurological disorders, and others. His methodological research includes evaluations of public health interventions, prevention/screening, diagnostic imaging procedures, personalized medicine, causal inference from “big” data, decision modelling, and study designs controlling for treatment switching. He teaches courses in decision-analytic modeling, HTA, economic evaluation, analysis of big data, and advanced causal epidemiologic methods at several universities and for industry in Europe, USA, South America, and Asia.


1980  B.Sc. Gymnasium Giengen, Germany (Mathematics, Chemistry)
1991  M.D. Ludwig-Maximilians-University of Munich, Germany
1996 Licensure to practice General Medicine, State of Bavaria, Germany
1996  M.P.H. Postgraduate School of Public Health and Epidemiology, Ludwig-Maximilians-University of Munich, Germany
2000  S.M. Master of Science in Epidemiology, Harvard School of Public Health, Boston, MA, USA
2002 Board Certificate in Epidemiology, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)
2004 Board Certificate in Biostatistics in Medicine, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)
2005  S.D. Doctor of Science in Health Policy and Management, Harvard School of Public Health, Boston, MA, USA